Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-05-22
2007-05-22
O'Hara, Eileen B. (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C435S069100, C514S002600, C514S008100, C514S012200, C536S023500
Reexamination Certificate
active
09037657
ABSTRACT:
The present invention relates generally to a novel haemopoietin receptor or derivatives thereof and to genetic sequences encoding same. Interaction between the novel receptor of the present invention and a cytokine ligand facilitates proliferation, differentiation and survival of a wide variety of cells. The novel receptor and its derivatives and the genetic sequences encoding same of the present invention are useful in the development of a wide range of agonists, antagonists, therapeutics and diagnostic reagents based on ligand interaction with its receptor.
REFERENCES:
patent: 138133 (1985-04-01), None
patent: WO9008822 (1990-08-01), None
George et al. Macromolecular Sequencing and Synthesis, Alan R.Liss, Inc; New York, Chapter 12, pp. 127-149, 1988.
Marra et al. (Accession No. W66776), The WashU-HHMI Mouse EST Project, Jun. 1996.
Baumann, et al. (Oct. 25, 1991) “Interleukin—11 Regulates the Hepatic Expression of the Same Plasma Protein Genes as Interleukin—6”,The Journal of Biological Chemistry 266(30) :20424-20427.
Bazan (Sep. 1990) “Structural Design and Molecular Evolution of a Cytokine Receptor Superfamily”,Proc. Natl. Acad. Sci. USA 87:6934-6938.
Burstein,. et al. (1992) “Leukemia Inhibitory Factor and Interleukin-11 Promote Maturation of Murine and Human MegakaryocytesIn Vitro”, Journal of Cellular Physiology 153:305-312.
Cwirla, et al. (Jun. 13, 1997) “Peptide Agonist of the Thrombopoietin Receptor as Potent as the Natural Cytokine”,Science 276:1696-1699.
Davis, et al. (Dec. 27, 1996) “Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning”,Cell 87:1161-1169.
De Vos, et al. (Jan. 17, 1992) “Human Growth Hormone and Extracellular Domain of its Receptor: Crystal Structure of the Complex”,Science 255:306-312.
Du, et al. (Apr. 15, 1994) “Interleukin-11: A Multifunctional Growth Factor Derived From the Hematopoietic Microenvironment”,Blood 83(8):2023-2030.
Gearing, et al. (Jul. 12, 1991) “Homology of the p40 Subunit of Natural Killer Cell Stimulatory Factor (NKSF) with the Extracellular Domain of the Interleukin-6 Receptor”,Cell 66:9-10.
Hangoc, et al. (Feb. 15, 1993) “In VivoEffects of Recombinant Interleukin-11 on Myelopoiesis in Mice”,Blood 81(4):965-972.
Hirata, et al. (1994) “ADP Ribosyl Cyclase Activity of a Novel Bone Marrow Stromal Cell Surface Molecule”,FEBS Letters 356:244-248.
Kawashima, et al. (1991) “Molecular Cloning of cDNA Encoding Adipogenesis Inhibitory Factor and Identity with Interleukin-11”,FEBS Letters 283(2):199-202.
Keller, et al. (Sep. 1, 1993) “Interleukin-11 Inhibits Adipogenesis and Stimulates Myelopoiesis in Human Long-Term Marrow Cultures”,Blood 82(5):1428-1435.
Layton, et al. (Sep. 1992) “A Major Binding Protein for Leukemia Inhibitory Factor in Normal Mouse Serum: Identification as a Soluble Form of a Cellular Receptor”,Proc. Natl. Acad. Sci. USA 89:8616-8620.
Livnah, et al. (Jul. 26, 1996) “Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å”,Science 273: 464-471.
Merberg, et al. (1992) “Sequence Similarity Between NKSF and the IL-6/G-CSF Family”,Immunology Today 13(2):77-78.
Mizushima, et al. (1990) “pEF-BOS, a Powerful Mammalian Expression Vector”,Nucl. Acids Research 18(17):5322.
Musashi, et al. (Sep. 15, 1991) “Synergistic Interactions Between Interleukin-11 and Interleukin-4 in Support of Proliferation of Primitive Hematopoietic Progenitors of Mice”,Blood 78(6):1448-1451.
Paul, et al. (Oct. 1990) “Molecular Cloning of a cDNA Encoding Interleukin 11, a Stromal Cell-Derived Lymphopoietic and Hematopoietic Cytokine”,Proc. Natl. Acad. Sci. USA 87:7512-7516.
Yang, et al. (1992) “Interleukin-11 and its Receptor”,Biofactors 4(1):15-21.
Yonemura, et al. (1992) “Synergistic Effects of Interleukin 3 and Interleukin 11 on Murine Megakaryopoiesis in Serum-Free Culture”,Exp. Hematol. 20:1011-1016.
Schibler, et al. (Aug. 15, 1992) “Effect of Interleukin-11 on Cycling Status and Clonogenic Maturation of Fetal and Adult Hematopoietic Progenitors”,Blood 80(4):900-903.
Suri, et al. (Dec. 27, 1996) “Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, During Embryonic Angiogenesis”,Cell 87:1171-1180.
Toga, et al. (Aug. 11, 1989) “Interleukin-6 Triggers the Association of its Receptor With a Possible Signal Transducer, gp130”,Cell 58:573-581.
Teramura, et al. (Jan. 15, 1992) “Interleukin-11 Enhances Human MegakaryocytopoiesisIn Vitro”, Blood 79(2):327-331.
Tsuji, et al. (Jun. 1, 1992) “Enhancement of Murine Hematopoiesis by Synergistic Interactions Between Steel Factor (Ligand for c-kit), Interleukin-11, and Other Early Acting Factors in Culture”,Blood 79(11):2855-2860.
Wrighton, et al. (Jul. 26, 1996) “Small Peptides as Potent Mimetics of the Protein Hormone Erythropoietin”,Science 273:458-463.
Alexander Warren
Fabri Louis
Farley Alison
Hilton Douglas J.
Kikuchi Yasufumi
Hamud Fozia
O'Hara Eileen B.
Scully , Scott, Murphy & Presser, P.C.
Zenyth Operations Pty Ltd
LandOfFree
Haemopoietin receptor and genetic sequence encoding same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Haemopoietin receptor and genetic sequence encoding same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Haemopoietin receptor and genetic sequence encoding same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760636